Clinical Trials Browser

Phase EARLY_PHASE1 × Neoplasms × poly ICLC × Clear all

NCT00874861 2015-12-08

HLA-A2-Restricted Glioma Antigen-Peptides Vaccinations With Poly-ICLC for Recurrent WHO Grade II Gliomas

Phase EARLY_PHASE1 Completed

Astrocytoma, Neoplasms, Oligodendroglioma